Recent PET results indicate that the benzodiazepine (BZ) PET" method. (J Neurol Neurosurg Psychiatry 1993;56:61 5-621) The search for potential biochemical markers of epileptic foci has therefore continued. In a recent PET study, it has been demonstrated that the density of the postsynaptic benzodiazepine (BZ) receptor, a well-known mediator of cortical inhibition, is significantly reduced in human epileptic foci.6 This observation suggests that studies of the BZ receptor with ['1C]flumazenil might be used for preoperative visualisation and localisation of epileptic foci. In this study we compared the applicability of this method with PET measurements of rCMRAUZ. The EEG recording from intracranial electrodes was the independent reference method.
epileptic foci. The present study examines the applicability of this finding in the presurgical investigation of patients with intractable partial epilepsy. In eight patients, the PET measurements were performed after injection of the BZ receptor antagonist ['tCjflumazenil and [2-l'8F]2-deoxy-2-fluoro-D-glucose ([58FJFDG)-a tracer for measurements of the rate of regional glucose metabolism. The focus localising ability of the two PET tracers was examined using extra-and intracranial EEG recordings as reference. The focus was first determined visually on the PET images obtained after a bolus injection of each of the PET tracers. Its anatomical localisation and spatial delimitation was then evaluated for each patient with a computerised anatomical brain atlas.
["CJflumazenil was found to be a more sensitive and accurate focus localiser than [18F]FDG. This observation was valid both for quantified and nonquantified images. In the preoperative diagnosis of epileptic foci, the PET measurements of BZ receptors may be a suitable and, in some cases, superior method to the generally used "'[18FJFDG- PET" The search for potential biochemical markers of epileptic foci has therefore continued. In a recent PET study, it has been demonstrated that the density of the postsynaptic benzodiazepine (BZ) receptor, a well-known mediator of cortical inhibition, is significantly reduced in human epileptic foci.6 This observation suggests that studies of the BZ receptor with [ '1C]flumazenil might be used for preoperative visualisation and localisation of epileptic foci. In this study we compared the applicability of this method with PET measurements of rCMRAUZ. The EEG recording from intracranial electrodes was the independent reference method.
The study had the following objectives: 1) to analyse the sensitivity and specificity of #The ratio focus/multilobular cortical ROI was not significantly altered from normal. *Bilateral temporal foci were revealed with the "BZ method" by means of bilaterally low ratios compared with the controls. **Valproic acid was under withdrawal for clinical reasons (current dose 300mg daily). amy = amygdala; prec = precentral gyrus; cin = cingular gyrus; rec = gyrus rectus; fi = inferior frontal gyrus; sma = supplementary motor area; fin = medial frontal gyrus; ti = inferior temporal gyrus; fs = superior frontal gyrus; tm = medial temporal gyrus; hi = hippocampus; ts = superior temporal gyrus; ins = insula; t ant = anterior temporal cortex; orb = orbital gyrus; t lat = lateral temporal cortex; oct = occipito temporal gyrus; t mes = mesial temporal cortex ph = parahippocampus; unc = uncus; pa = parietal lobulus. Focus ROI = localisation of the visually predetermined focus; R = right; L = left; CPS = complex partial seizures; SDE = subdural electrodes.
were controlled in a standardised way (eyes open, ears unplugged, a dim and quiet environment).
Pet tracers ['Ciflumazenil
The selective benzodiazepine (BZ) receptor antagonist, flumazenil (Ro 15 1788) labelled in the N-methyl group with the positron emitting isotope carbon-1" was used as a marker of BZ receptors. The kinetics and binding properties of this ligand have been described previously.6 's '6 Each subject received two iv bolus injec- possible to obtain a spatial correlation between altered BZ receptor density and glucose metabolism in the epileptogenic regions. The three-dimensional standard brain atlas was first adapted to the MRI images (Siemens Magnetom, Germany; 1.0 tesla, spatial resolution 10 mm) of each patient by means of linear and non-linear transformations. Thereafter, the standard brain atlas was also fitted to the individual PET-images. The anatomical structures of the standard brain atlas were then called in from the data base and presented directly on the BZ-Bma, and the rCMRgu images. The structures obtained were used as guides for delineation of two dimensional regions. Forty atlas regions, extensively covering the temporal and frontal lobes, including samples from parietal and occipital lobes, were delineated in each patient. The size of the smallest region was about 1 2 cm3.
The mean (SD) values, the highest and lowest value of regional BZ receptor density and glucose metabolism were obtained for each ROI directly from the PET images.
Statistics
The statistical analysis was used to: 1) evaluate if the asymmetry between the visually defined focus ROI and the homotopic ROI was significant in relation to all calculated asymmetries in the same patient. This was attained by calculation of the confidence interval with regional asymmetries between various ROIs as input data. An asymmetry was considered as statistically significant if it exceeded the value for the 95% confidence interval. The confidence interval was calculated with the assumption of a t-distribution and DF = n-I 2) determine the anatomical atlas structures within and outside each focus ROI that had asymmetries that were significantly higher ( = outside the 95% confidence limit) than all the asymmetries of atlas delineated regions in the same patient. 3) evaluate if the ratios focus ROI/multilobar cortical ROI and homotopic ROI/multilobar cortical ROI were lower (= outside the 95% confidence limit) than the ratios for the corresponding region in healthy controls. The confidence limit for regional ratios in healthy controls was calculated with the assumption of a t-distribution and DF = n-1 4) test whether any of the methods for analysing the data (different types of PET images) gave a significantly better contrast than the other methods used. PET images showed that the B. images yielded a significantly higher degree of reduction in the focus ROI (p < 0-001), than the other three types of PET images (table 2a, b). According to both the BZ receptor and the [18F]FDG method there were no significant asymmetries in other ROIs than the focus ROI, which indicated good specificity. However, in the majority of patients with temporal lobe epilepsy the maximal reduction of BZ receptors was found in the mesial temporal cortex, whereas the maximal hypometabolism was confined to the lateral surface of the temporal lobe (the mean asymmetry was, according to BZ-B,, images, 50% in the mesial and 17% in the lateral temporal cortex; the corresponding values for the rCMRI,u were 8% and 25%). The intracranial EEG recordings from these patients showed that the epileptic seizures started in the mesial temporal lobe. Thus the focus region determined with the BZ receptor method was spatially better correlated to the EEG recordings than the hypometabolic region as determined with the FDG method.
Relationship between the predefined focus ROI and the atlas structures with significantly reduced BZ receptor density and rCMRgiu When the asymmetries of various homotopic atlas structures were analysed, the localisation of the focus ROIs defined visually on the rCMRZu and BZ-B, images was confirmed in all the patients (table 1). The extension of the atlas-determined area with reduced BZ receptor density was in several cases (patients 1,4,6) more limited than that indicated by the focus-ROI (table 1) . On the other hand in patients 2 and 5, the atlas analysis showed a significant reduction also outside the focus. In patient 2 this reduction could be related to a possible secondary focus (the EEG recordings showed a few seizures emigrating from the right temporal lobe) whereas in patient 5 the reduction was confined to a projectionarea to the focus (table 1) . 23 The results from the atlas based evaluation of the FDG method suggested somewhat poorer specificity: in all patients (except in patient 1) there were several hypometabolic atlas-regions outside the visually determined focus ROI (fig 1) . In addition to the methodological evaluation of ["C]flumazenil and [18F]FDG as focus markers, our study also permitted a comparison of the localisation and extension of the hypometabolic and BZ receptorreduced areas. Such a comparison was of interest since it has been speculated that altered inhibition may be a possible explanation for interictal focal hypometabolism. ' An interesting observation was that in several patients with mesial temporal EEG foci, the maximum hypometabolism was found laterally in the temporal lobe, whereas the maximum reduction of the BZ receptor density was confined to the mesial temporal lobe. A preliminary report supporting this finding was recently published. 26 Since the EEG focus probably reflects pathological firing patterns of a fraction of mesially located neurons,27 the most pronounced activation of GABAergic neurons is expected to be within the same area. 28 29 Such an activation may lead to a downregulation or blockade of the postsynaptic GABA/BZ receptor complex30 that in addition to the postulated cell loss in the intractable foci could explain the detected reduction of BZ receptor density.31 rCMRI, does not necessarily have to be decreased in an area receiving inhibitory input,'32 which may explain the relatively sparse hypometabolism in the mesial temporal cortex. However, since the more laterally localised neuronal synapses will not be activated due to the presumably increased mesial inhibition, the net metabolic ratio in the lateral temporal cortex will become considerably decreased. Our observation of maximum reduction of BZ receptor density in the mesio-anterior, and maximum hypometabolism in the lateral temporal lobe, may thus be explained as a mesial inhibition and lateral deactivation.
The results of the present PET studies warrant follow up experiments with a larger number of patients and with evaluation not only of the intracranial EEG recordings but also of the postsurgical outcome. An important future project would be to try to identify if there are subgroups of patients where one tracer is preferable to the other, or where a combination of both tracers will offer additional information for correct focus localisation.
